Oasis Fertility, a leading name in fertility care in India, in partnership with the Pune Obstetrics and Gynaecology Society (POGS), inaugurated the ART Conclave 2025 under the campaign theme “In the Good Hands of Science” at the Sheraton Grand, Pune.
Event Launch and Objectives
The event was officially launched by Dr. Kiran Kurtkoti, President of the Association of Maharashtra Obstetrics and Gynaecological Society (AMOGS), alongside distinguished professionals such as Dr. Arati Nimkar, President of POGS, and Dr. Durga G Rao, Co-Founder and Medical Director of Oasis Fertility. Other prominent figures included Dr. Nilesh Unmesh Balkawade, Regional Medical Head, Pushkaraj Shenai, CEO of Oasis Fertility, and Dr. Krishna Chaitanya M, Scientific Head and Clinical Embryologist.
The conclave aimed to emphasize the role of scientific advancements in addressing infertility and reproductive health challenges, leveraging cutting-edge technology and evidence-based treatments.
A Platform for Learning and Collaboration
The ART Conclave provided a unique educational platform, attracting over 180 participants, including fertility specialists, embryologists, gynaecologists, and researchers from across Maharashtra. The event featured hands-on training sessions covering critical areas such as Ovum Pick-Up (OPU), Semen Wash Techniques, and Hysteroscopy.
Expert talks by renowned national faculty explored diverse topics in infertility care, offering attendees valuable insights and practical strategies.
Key Highlights and Expert Insights
Dr. Durga G Rao remarked on the transformative power of science in fertility care:
“ART Conclave 2025 demonstrates how science turns challenges into opportunities. Workshops and sessions on topics like ‘ART Law’ and ‘Unexplained Infertility’ aim to enhance professional skills and promote ethical practices.”
Dr. Krishna Chaitanya M emphasized the importance of innovation and evidence-based care:
“Our theme, ‘In the Good Hands of Science,’ reflects our dedication to addressing infertility through advancements in male fertility treatments, IVF protocols, and public awareness efforts. These insights empower individuals to make informed fertility decisions.”
Dr. Nilesh Unmesh Balkawade highlighted the role of technology and artificial intelligence in reproductive medicine:
“Science and AI are transforming reproductive healthcare. With individualized care and advanced technologies, we aim to provide hope and solutions for those facing fertility challenges.”
Advancing Fertility Care Through Innovation
Pushkaraj Shenai, CEO of Oasis Fertility, reaffirmed the organization’s commitment to accessible and impactful treatments:
“Our mission is to combine precision and care, fostering innovation in reproductive medicine to turn dreams of parenthood into reality. Through collaboration with leading professionals, we aim to make advanced treatments widely available.”
Comprehensive Sessions and Community Impact
The conclave featured focused sessions on Unexplained Infertility, Male Fertility, and IVF Advancements, led by key experts. A panel discussion on “When to Refer for IVF” provided actionable guidance for healthcare professionals. Additionally, an interactive quiz session engaged attendees, offering attractive prizes for active participation.
Oasis Fertility: A Leader in Fertility Solutions
Oasis Fertility continues to lead in reproductive healthcare, offering advanced technologies like Preimplantation Genetic Testing for Aneuploidies (PGT-A), aiding couples with chromosomal abnormalities. The organization has also pioneered CAPA In Vitro Maturation (IVM), a drug-free IVF option particularly beneficial for patients with PCOS or challenging IVF histories.
The ART Conclave 2025 underscored Oasis Fertility’s commitment to advancing fertility care and fostering hope for couples striving to achieve parenthood.
Related topics:
Bariatric Surgery’s Role in Enhancing Fertility: A Growing Solution for Obesity-Related Infertility
IVF’s Role in Overcoming Male Infertility: A Comprehensive Approach
Couple Sues Fertility Company Over Costly IVF Embryo Destruction